Coinciding with World Rare Disease Day, IGTP launches a new episode of its podcast 'Un bri de ciència'. Researcher Gisela Nogales discusses her projects on neuromuscular diseases and emphasises her commitment to supporting patients and providing solutions.
At the IGTP TODAY
On 7 February, "#100tífiques" returned for its sixth edition, a macro-event that has become a benchmark for advocacy within the Catalan female research community and schools. Expanding on last year's participant numbers, thirteen scientists from IGTP took part in this event.
A newly developed therapeutic strategy offers potential in treating neurofibromatosis type 1 skin tumours
Researchers from IGTP have made progress exploring potential treatments for skin tumours associated with neurofibromatosis type 1. Their findings in cell models have been published in the journal JCI Insight.
To better understand the complexity of P. vivax infections, the CaixaResearch project "Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria" has produced this video to disseminate key insights into cryptic erythrocytic infections. The initiative is led by Hernando A del Portillo and Carmen Fernandez-Becerra, group leaders of the Plasmodium vivax and Exosome Research Group (PvREX) at the Barcelona Institute for Global Health (ISGlobal) and the Germans Trias i Pujol Research Institute (IGTP) in Spain.
For the sixth consecutive year and in honour of the International Day of Women and Girls in Science, the Can Ruti Working Group Women for Equity in Science (formerly known as Women in Science) organised a symposium to reflect on the status of women in science. The event was held yesterday, 8 February, at the Germans Trias i Pujol Research Institute (IGTP) and was attended by over a hundred people in person and online. It focused on "Women and Leadership in Science".
An international team of researchers identifies the genetic basis and biological processes that influence cancer risk related to alterations in the number of immune cells present in blood. This is a significant advance in the understanding of how the immune system can prevent the appearance of tumours.
Two studies by CEEISCAT with the PISCIS cohort show that people living with HIV have been less vaccinated with the full initial regimen against COVID-19
The European Union launches the THRIVE project to improve the prognosis of children and adults with liver cancer
The European Union's project THRIVE held its kick-off meeting on 12 January 2024 in Barcelona. The project is coordinated by Josep M. Llovet (IDIBAPS). IGTP collaborates as a partner through c-LOG, led by Carolina Armengol.
Researchers from B·ARGO and the Urological Tumour Unit at IGTP and ICO have led a study proposing a new therapeutic strategy based on a combination of kinase inhibitors for metastatic prostate cancer patients who have progressed on standard treatment. The study has been published in the journal Frontiers in Pharmacology.
Research teams from BSC-CNS, UPV/EHU and IGTP are working on a project that uses artificial intelligence to predict and prevent type 2 diabetes. This initiative is part of the Complementary Plan for Biotechnology Applied to Health, coordinated by IBEC.